Published in N Engl J Med on January 06, 1994
Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases. Pediatr Nephrol (2008) 2.64
Long-term outcome of children treated with rituximab for idiopathic nephrotic syndrome. Pediatr Nephrol (2013) 1.63
Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial. Clin J Am Soc Nephrol (2011) 1.62
Recurrent Primary Focal Segmental Glomerulosclerosis Managed With Intensified Plasma Exchange and Concomitant Monitoring of Soluble Urokinase-Type Plasminogen Activator Receptor-Mediated Podocyte β3-integrin Activation. Transplantation (2015) 1.47
Glomerular overproduction of oxygen radicals in Mpv17 gene-inactivated mice causes podocyte foot process flattening and proteinuria: A model of steroid-resistant nephrosis sensitive to radical scavenger therapy. Am J Pathol (1999) 1.25
Rituximab treatment of adult patients with steroid-resistant focal segmental glomerulosclerosis. Clin J Am Soc Nephrol (2009) 1.21
Serum suPAR in patients with FSGS: trash or treasure? Pediatr Nephrol (2013) 1.13
Induction of T regulatory cells attenuates idiopathic nephrotic syndrome. J Am Soc Nephrol (2008) 1.11
Disease recurrence in paediatric renal transplantation. Pediatr Nephrol (2009) 1.10
TRPpathies. J Physiol (2006) 1.04
Nephrotic syndrome and rituximab: facts and perspectives. Pediatr Nephrol (2009) 1.01
Rituximab for refractory focal segmental glomerulosclerosis. Pediatr Nephrol (2007) 1.00
Recurrence of nephrotic syndrome/focal segmental glomerulosclerosis following renal transplantation in children. Pediatr Nephrol (2006) 0.99
Extrarenal effects on the pathogenesis and relapse of idiopathic nephrotic syndrome in Buffalo/Mna rats. J Clin Invest (2002) 0.98
Single-center analysis of early recurrence of nephrotic syndrome following renal transplantation in children. Pediatr Transplant (2001) 0.91
Early use of plasmapheresis for recurrent post-transplant FSGS. Pediatr Nephrol (2003) 0.87
Imbalances in serum proinflammatory cytokines and their soluble receptors: a putative role in the progression of idiopathic IgA nephropathy (IgAN) and Henoch-Schönlein purpura nephritis, and a potential target of immunoglobulin therapy? Clin Exp Immunol (1998) 0.87
Predictive urinary biomarkers for steroid-resistant and steroid-sensitive focal segmental glomerulosclerosis using high resolution mass spectrometry and multivariate statistical analysis. BMC Nephrol (2014) 0.86
Circulating anti-actin and anti-ATP synthase antibodies identify a sub-set of patients with idiopathic nephrotic syndrome. Clin Exp Immunol (2005) 0.83
The pediatric nephrotic syndrome spectrum: clinical homogeneity and molecular heterogeneity. Pediatr Transplant (2004) 0.83
Rituximab: is replacement of cyclophosphamide and calcineurin inhibitors in steroid-dependent nephrotic syndrome possible? Pediatr Nephrol (2007) 0.83
Rituximab and minimal change nephrotic syndrome: a therapeutic option. Clin Exp Nephrol (2011) 0.82
Is there a role for rituximab in the treatment of idiopathic childhood nephrotic syndrome? Pediatr Nephrol (2007) 0.82
Circulating Permeability Factors in Primary Focal Segmental Glomerulosclerosis: A Review of Proposed Candidates. Biomed Res Int (2016) 0.82
Issues in solid-organ transplantation in children: translational research from bench to bedside. Clinics (Sao Paulo) (2014) 0.81
Long-term outcome of focal segmental glomerulosclerosis after pediatric renal transplantation. Pediatr Nephrol (2009) 0.81
Toll-like receptor 3 expression and function in childhood idiopathic nephrotic syndrome. Clin Exp Immunol (2015) 0.79
Monoclonal antibodies for podocytopathies: rationale and clinical responses. Nat Rev Nephrol (2009) 0.79
Beneficial effect of LDL-apheresis in refractory nephrotic syndrome. Clin Exp Nephrol (2014) 0.79
Immunopathogenesis of idiopathic nephrotic syndrome with relapse. Semin Immunopathol (2014) 0.78
Peritoneal protein losses in children with steroid-resistant nephrotic syndrome on continuous-cycler peritoneal dialysis. Pediatr Nephrol (2006) 0.78
Expression of immunoglobulin E-dependent histamine-releasing factor in idiopathic nephrotic syndrome of childhood. Clin Exp Immunol (2005) 0.78
Advances in apheresis therapy for glomerular diseases. Clin Exp Nephrol (2007) 0.78
Principles of separation: indications and therapeutic targets for plasma exchange. Clin J Am Soc Nephrol (2013) 0.77
High cut-off haemodialysis induces remission of recurrent idiopathic focal segmental glomerulosclerosis after renal transplantation but is no alternative to plasmapheresis. NDT Plus (2011) 0.75
Renal biopsy: use of biomarkers as a tool for the diagnosis of focal segmental glomerulosclerosis. Dis Markers (2014) 0.75
Plasma Exchange for the Recurrence of Primary Focal Segmental Glomerulosclerosis in Adult Renal Transplant Recipients: A Meta-Analysis. J Transplant (2015) 0.75
Permeability factors in nephrotic syndrome and focal segmental glomerulosclerosis. Kidney Res Clin Pract (2012) 0.75
Idiopathic nephrotic syndrome: the EBV hypothesis. Pediatr Res (2016) 0.75
The anti-CD40 auto-antibody: a biomarker or a factor for the permeability of recurrent focal segmental glomerulosclerosis? Ann Transl Med (2015) 0.75
Pathogenesis of "idiopathic" nephrotic syndrome. N Engl J Med (1994) 0.75
Genetics of childhood steroid-sensitive nephrotic syndrome. Pediatr Nephrol (2016) 0.75
Optimal management of primary focal segmental glomerulosclerosis in adults. Int J Nephrol Renovasc Dis (2017) 0.75
Multiple Targets for Novel Therapy of FSGS Associated with Circulating Permeability Factor. Biomed Res Int (2017) 0.75
Steroid-responsive nephrotic syndrome in a child with juvenile idiopathic arthritis. Pediatr Nephrol (2007) 0.75
NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet (2000) 7.98
A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). Am J Transplant (2010) 5.40
A common core RNP structure shared between the small nucleoar box C/D RNPs and the spliceosomal U4 snRNP. Cell (2000) 4.33
Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet (1998) 3.77
Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group. Transplantation (1999) 2.81
Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet (1997) 2.38
Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group. Lancet (1997) 2.12
Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study. Am J Transplant (2010) 2.03
Heterodimerization of the IL-2 receptor beta- and gamma-chain cytoplasmic domains is required for signalling. Nature (1994) 1.93
Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients. Am J Transplant (2011) 1.93
[Meningoencephalitis, expression of Epstein-Barr virus primary infection in a patient with renal transplantation. Value of the search of the viral genome by PCR]. Presse Med (1994) 1.92
Long-term allograft tolerance is characterized by the accumulation of B cells exhibiting an inhibited profile. Am J Transplant (2010) 1.88
Diagnosis of brain death using two-phase spiral CT. AJNR Am J Neuroradiol (1998) 1.86
Comparison of transcriptional and blood cell-phenotypic markers between operationally tolerant liver and kidney recipients. Am J Transplant (2011) 1.78
Individualized mycophenolate mofetil dosing based on drug exposure significantly improves patient outcomes after renal transplantation. Am J Transplant (2007) 1.76
Rituximab therapy for childhood-onset systemic lupus erythematosus. J Pediatr (2006) 1.70
Novel mutations in the thiazide-sensitive NaCl cotransporter gene in patients with Gitelman syndrome with predominant localization to the C-terminal domain. Kidney Int (1998) 1.66
Initial presentation of childhood-onset systemic lupus erythematosus: a French multicenter study. J Pediatr (2005) 1.66
Close phenotypic and functional similarities between human and murine alphabeta T cells expressing invariant TCR alpha-chains. J Immunol (1997) 1.63
Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation. Am J Transplant (2012) 1.60
Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis. Kidney Int (1993) 1.56
H deficiency in two brothers with atypical dense intramembranous deposit disease. Kidney Int (1986) 1.55
Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting. Results of a prospective randomized trial. Cancer (1994) 1.55
A mutant mitochondrial respiratory chain assembly protein causes complex III deficiency in patients with tubulopathy, encephalopathy and liver failure. Nat Genet (2001) 1.55
Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database. Am J Hum Genet (1998) 1.54
Alefacept combined with tacrolimus, mycophenolate mofetil and steroids in de novo kidney transplantation: a randomized controlled trial. Am J Transplant (2013) 1.48
Haemolytic uraemic syndrome: prognostic factors in children over 3 years of age. Pediatr Nephrol (1995) 1.45
FTY720 versus MMF with cyclosporine in de novo renal transplantation: a 1-year, randomized controlled trial in Europe and Australasia. Am J Transplant (2006) 1.45
Safety and long-term efficacy of eculizumab in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome. Am J Transplant (2009) 1.44
Impact of cyclosporine reduction with MMF: a randomized trial in chronic allograft dysfunction. The 'reference' study. Am J Transplant (2006) 1.44
Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients. Ann Oncol (2000) 1.43
Long-term results (10 years) of a prospective trial comparing Lo-tact-1 monoclonal antibody and anti-thymocyte globulin induction therapy in kidney transplantation. Transpl Int (2006) 1.42
Decrease in renal vascular resistance in University of Wisconsin solution preserved kidney transplants. J Urol (1991) 1.40
Long-term results of renal transplantation in children with the prune-belly syndrome. J Urol (1997) 1.38
Hair and skin disorders as signs of mitochondrial disease. Pediatrics (1999) 1.38
Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss. Am J Transplant (2013) 1.36
Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts. N Engl J Med (1990) 1.35
Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Paf-acether and acetyl-transferase activity in human leukocytes. J Immunol (1984) 1.34
The role of nonclassical Fc receptor-associated, Ag-B antigens (Ia) in rat allograft enhancement. J Exp Med (1976) 1.33
A versatile ELISA-PCR assay for mRNA quantitation from a few cells. Biotechniques (1993) 1.31
A high affinity binding site for the HIV-1 nucleocapsid protein. Nucleic Acids Res (1997) 1.29
Immunoglobulin A nephropathy. Quantitative immunohistomorphometry of the tonsillar plasma cells evidences an inversion of the immunoglobulin A versus immunoglobulin G secreting cell balance. J Clin Invest (1983) 1.29
Kenny-Caffey syndrome in two sibs born to consanguineous parents: evidence for an autosomal recessive variant. Am J Med Genet (1992) 1.26
Prosthetic repair of a perforated Amyand's hernia: hazardous or feasible? Hernia (2007) 1.26
Risk factors and long-term outcome of transplant renal artery stenosis in adult recipients after treatment by percutaneous transluminal angioplasty. Am J Transplant (2006) 1.25
Comparison of nested PCR for detection of DNA in plasma with pp65 leukocytic antigenemia procedure for diagnosis of human cytomegalovirus infection. J Clin Microbiol (1994) 1.25
Efficacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: concept study. Am J Transplant (2009) 1.24
Sirolimus versus cyclosporine in kidney recipients receiving thymoglobulin, mycophenolate mofetil and a 6-month course of steroids. Am J Transplant (2007) 1.22
Incidence and consequences of post-transplantation lymphoproliferative disorders. J Nephrol (1997) 1.20
Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N Engl J Med (1991) 1.18
A soluble interleukin 2 receptor produced by a normal alloreactive human T cell clone binds interleukin 2 with low affinity. J Immunol (1987) 1.17
Population pharmacokinetics and pharmacogenetics of tacrolimus in de novo pediatric kidney transplant recipients. Clin Pharmacol Ther (2009) 1.17
Rat spleen dendritic cells express natural killer cell receptor protein 1 (NKR-P1) and have cytotoxic activity to select targets via a Ca2+-dependent mechanism. J Exp Med (1997) 1.17
Natural splicing of exon 2 of human interleukin-15 receptor alpha-chain mRNA results in a shortened form with a distinct pattern of expression. J Biol Chem (1999) 1.17
Specific transplantation tolerance induced by spontaneously tolerated liver allograft in inbred strains of rats. Transplantation (1980) 1.16
The nephropathy associated with male pseudohermaphroditism and Wilms' tumor (Drash syndrome): a distinctive glomerular lesion--report of 10 cases. Clin Nephrol (1985) 1.16
Mapping of avirulence genes in Phytophthora infestans with amplified fragment length polymorphism markers selected by bulked segregant analysis. Genetics (2001) 1.16
The natural history of clinical operational tolerance after kidney transplantation through twenty-seven cases. Am J Transplant (2012) 1.15
Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneys. Kidney Int (1998) 1.15
The archaeal sRNA binding protein L7Ae has a 3D structure very similar to that of its eukaryal counterpart while having a broader RNA-binding specificity. J Mol Biol (2004) 1.14
Congenital nephrotic syndrome of the Finnish type: linkage to the locus in a non-Finnish population. Pediatr Nephrol (1996) 1.14
Transcriptional and post-transcriptional alterations of IkappaBalpha in active minimal-change nephrotic syndrome. J Am Soc Nephrol (2001) 1.14
Molecular properties of the action potential Na+ ionophore in neuroblastoma cells. Interactions with neurotoxins. J Biol Chem (1978) 1.13
A critical role for transforming growth factor-beta in donor transfusion-induced allograft tolerance. J Clin Invest (1998) 1.13
Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor gamma. Biochem Biophys Res Commun (1992) 1.13
Usefulness of DNA viral load quantification for cytomegalovirus disease monitoring in renal and pancreas/renal transplant recipients. Transplantation (1997) 1.13
[Practical interest of the determination of urinary fibrin degradation products in the early monitoring of kidney transplants]. Pathol Biol (Paris) (1983) 1.13
Lectins as markers of human epidermal cell differentiation. Differentiation (1982) 1.12
Management of steroid-responsive nephrotic syndrome. Pediatr Nephrol (2000) 1.12
Identification of a tetrodotoxin-sensitive Na+ channel in a variety in fibroblast lines. Nature (1980) 1.12
Antirespiratory and antiproliferative activity of anthralin in cultured human keratinocytes. J Invest Dermatol (1985) 1.11
Eculizumab: safety and efficacy after 17 months of treatment in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome: case report. Transplant Proc (2010) 1.11
Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/or decay-accelerating factor. Transplantation (1994) 1.10
Expansion of cortical interstitium is limited by converting enzyme inhibition in type 2 diabetic patients with glomerulosclerosis. The Diabiopsies Group. J Am Soc Nephrol (1999) 1.10
The sodium channel in non-impulsive cells. Interaction with specific neurotoxins. Biochim Biophys Acta (1979) 1.09
X-linked hypohidrotic ectodermal dysplasia and t(X;12) in a female. Clin Genet (1989) 1.09
Surface markers and electron microscopy of human blood L cells: a comparison with T and B lymphocytes. J Immunol (1978) 1.08
Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression. Transplantation (2001) 1.08
Impairment of lung diffusion capacity in Schönlein-Henoch purpura. J Pediatr (1992) 1.07
Caspase-independent cell death induced by anti-CD2 or staurosporine in activated human peripheral T lymphocytes. J Immunol (1998) 1.07
Mapping a gene (SRN1) to chromosome 1q25-q31 in idiopathic nephrotic syndrome confirms a distinct entity of autosomal recessive nephrosis. Hum Mol Genet (1995) 1.07
Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial. Blood (2001) 1.06
Deletion of mitochondrial DNA in patient with chronic tubulointerstitial nephritis. J Pediatr (1995) 1.06
Insertion of a double pigtail ureteral stent for the prevention of urological complications in renal transplantation: a prospective randomized study. J Urol (1996) 1.05
Stimulation of leukemia inhibitory factor receptor degradation by extracellular signal-regulated kinase. J Biol Chem (2000) 1.05
Transgenesis in rats: technical aspects and models. Transgenic Res (1996) 1.05
The kidney in mitochondrial cytopathies. Kidney Int (1997) 1.05
Long-term follow-up of ifosfamide renal toxicity in children treated for malignant mesenchymal tumors: an International Society of Pediatric Oncology report. J Clin Oncol (1991) 1.04
WT1 and PAX-2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis. Am J Pathol (1999) 1.04
Percutaneous transluminal angioplasty of renal artery stenosis in children. Pediatr Radiol (1998) 1.04
Efficacy of double intrauterine insemination in controlled ovarian hyperstimulation cycles. Fertil Steril (1999) 1.04
Clonal expansion of lymphocytes bearing the gamma delta T-cell receptor in a patient with large granular lymphocyte disorder. Blood (1989) 1.03
PAX2 mutations in oligomeganephronia. Kidney Int (2001) 1.03
Phenotypes of 'null' lymphoid cells in human blood. Scand J Immunol (1979) 1.02
Is it time to revise the normal range of serum uric acid levels? Eur Rev Med Pharmacol Sci (2014) 1.02
Complicated lymphoceles after kidney transplantation. Transplant Proc (2010) 1.02